Elastomer infusion pumps are disposable medical devices that are used for administration of intravenous (IV) drugs such as antibiotics, analgesics, chemotherapy, and other medications. These devices use energy in an elastic membrane (inside the pump) to provide the force for drug delivery. In addition, it provides advantages over conventional electronic pumps in features such as portability, feasibility, and lesser scope for human errors. However, pump failure can have a significant impact on patient safety, making it required for pumps to be operated by a trained professional. The two major types of elastomer infusion pumps are continuous rate pumps, and variable rate pumps.
The global elastomer infusion pump market size was valued at $534 million in 2018, and is projected to reach $745 million by 2026, growing at a CAGR of 4.2% from 2019 to 2026.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/6323
The major factors that boost the growth of the global elastomer infusion pump market are increase in demand for elastomer infusion pumps, rise in prevalence of chronic diseases, increase in number of surgeries, surge in preference for long-term home healthcare, technological development of novel elastomeric infusion pumps, rise in burden on hospitals to reduce healthcare costs, and rise in availability of elastomer infusion pumps. In addition, factors such as longer storage and stability of the drug, reduced cost, portability and reduce risk of introduction of an infection, are expected to further influence the growth of the elastomer infusion pumps market. However, low income and lack of proper medical attention in the developing countries hamper the growth of the elastomer infusion pump market.
By application, the global elastomer infusion pump market is segmented into pain management, infection management, chemotherapy, and others. Pain management is the major shareholder in the global elastomer infusion pump market owing to rise in number of orthopedic procedures & surgeries, increase in use of elastomer infusion pumps for administration of analgesic drugs, and less complications are observed as compared to opioids dosage are the key drivers of the pain management segment.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/6323
Based on product, the elastomer infusion pump market is categorized into continuous rate pumps, and variable rate pumps. Presently, continuous rate pumps dominates the global market, and is anticipated to continue this trend during the forecast period. The key factors that drive the elastomer infusion pump market growth are rise in demand for continuous rate elastomeric pumps, wide usage of continuous rate pumps in chronic disease treatment, increase in adoption of elastomer infusion pump for post-operative pain management, and increase in application in cancer treatment are majorly driving the growth of this segment.
In 2018, North America accounted for the major share in the elastomer infusion pump market, and is expected to continue this trend during the forecast period, owing to availability of well-developed infrastructure, higher number of R&D activities with large presence of key players, rise in demand for elastomers infusion pumps, surge in prevalence of chronic diseases, and increase in non-government & government initiatives to promote healthcare. However, Asia-Pacific is expected to register the highest growth in the future owing to improvement in healthcare infrastructure, and technological advancements in the field of healthcare, and the developing R&D sector.
The Major Key Players Are:
Braun Melsungen Ag, Baxter International Inc., Halyard Health, Heka Healthcare, Nipro Medical Corporation (Nipro Medical Europe NV), Palex Medical SA, Pfizer Inc. (Hospira Inc.), Pfm Medical Ag, and PROMECON GmbH.
Access Full Report @ https://www.alliedmarketresearch.com/elastomer-infusion-pump-market-A05958
Key Findings of the Study
Depending on product, the continuous rate pumps segment held 57.22% share in the global market in 2018.
On the basis of application, the pain management segment held the largest elastomer infusion pump market share in 2018 and is expected to remain dominant throughout the forecast period.
According to end user, the home care segment exhibits fastest growth and is expected to grow at a CAGR of 5.3% from 2019 to 2026.
Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 5.9% during the forecast period.
Prostate Cancer Treatment Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
Laboratory Automation Market: Global Opportunity Analysis and Industry Forecast, 2021–2030
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Release ID: 89034652